Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -0.68 % |
3 Month Return | + 12.41 % |
1 Year Return | -9.38 % |
Market Stats | |
Previous Close | ₹32.25 |
Open | ₹31.46 |
Volume | 872.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹33.19Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹33.19 Cr |
P/B Ratio | 6.11 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Healthcare |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹33.19 Cr | -2.33% | 0.58 | NA | NA | |
NA | ₹111.94 Cr | 3.66% | 0.50 | ₹45 Cr | ₹59 Cr | |
NA | ₹4,390.99 Cr | 237.53% | 0.56 | NA | NA | |
NA | ₹237.16 Cr | 3.16% | 0.53 | ₹10 Cr | ₹48 Cr | |
BUY | ₹3,971.89 Cr | 235.67% | 0.71 | ₹49 Cr | ₹878 Cr |
Organisation | Aspira Pathlab & Diagnostics Ltd |
Headquarters | Mumbai |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for Aspira Pathlab & Diagnostics Ltd
Aspira Pathlab & Diagnostics reported a 12.04% YoY increase in net sales for March 2024, with quarterly net loss at Rs. 0.50 crore down 93.84% from the previous year. The stock has given -29.40% returns over the last 6 months and -3.87% over the last 12 months.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 81.28% of holdings in Jun 2024 quarter
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 128.3% return, outperforming this stock by 186.0%
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 79.5% return, outperforming this stock by 88.9%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 18.72% of holdings in Jun 2024 quarter
Price Dip
In the last 3 years, Aspira Pathlab stock has moved down by -57.7%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 18.72% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 81.28% | 0.00 | |
Others | 0% | 0.00 |
Aspira Pathlab & Diagnostics Ltd’s net profit jumped 106.94% since last year same period to ₹0.05Cr in the Q1 2024-2025. On a quarterly growth basis, Aspira Pathlab & Diagnostics Ltd has generated 110% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Aspira Pathlab & Diagnostics Ltd is currently in a Bullish trading position according to technical analysis indicators.
Aspira Pathlab & Diagnostics Ltd (540788) share price today is ₹33
Aspira Pathlab & Diagnostics Ltd is not listed on NSE
Aspira Pathlab & Diagnostics Ltd is listed on BSE
Today’s traded volume of Aspira Pathlab & Diagnostics Ltd(540788) is 872.00.
Today’s market capitalisation of Aspira Pathlab & Diagnostics Ltd(540788) is ₹33.19Cr.
Aspira Pathlab & Diagnostics Ltd(540788 | Price |
---|---|
52 Week High | ₹43.95 |
52 Week Low | ₹25 |
Aspira Pathlab & Diagnostics Ltd(540788) share price is ₹33. It is down -24.91% from its 52 Week High price of ₹43.95
Aspira Pathlab & Diagnostics Ltd(540788) share price is ₹33. It is up 32.00% from its 52 Week Low price of ₹25
Aspira Pathlab & Diagnostics Ltd(540788 | Returns |
---|---|
1 Day Returns | 0.75% |
1 Month Returns | -0.68% |
3 Month Returns | 12.41% |
1 Year Returns | -9.38% |